Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • WCM Congress

Basal cell carcinoma – What therapies are available for advanced forms?

    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • RX
  • 3 minute read

New avenues in the treatment of basal cell carcinoma (BCC) are being intensively discussed by current researchers. In particular, the functioning and inhibition of the Hedgehog signaling pathway offers an interesting field for understanding tumorigenesis and thus its suppression. This is all the more important because BCC is a very common form of cancer worldwide.

Basal cell carcinoma (BCC) is the most commonly diagnosed malignant tumor in the world (Table 1). According to Prof. Rainer Kunstfeld, MD, Vienna, UV radiation is one of the most important causes of BCC because it leads to cumulative damage to DNA and gene mutations. The majority of BCC occurs on the head and neck. Epidemiologic data indicate that incidence is increasing significantly worldwide and varies widely geographically. Australia is particularly hard hit, with an annual rate of 1-2%.

There are several clinical subtypes (Table 2). In each case, the degree of severity must be considered: Locally advanced forms of BCC occur in only a few patients, but they include lesions that cannot be addressed surgically or only by surgery associated with disfigurement. A BCC that develops distant metastases in bones, lungs or liver or occurs with involvement of the lymph nodes is also rare, but then associated with a prognosis that is all the worse: The average survives only 8-14 months.

In hereditary Gorlin-Goltz syndrome, multiple BCCs form, predominantly visible on the face. Treatment can be done only by frequent surgery and cryotherapy.

Femur fracture due to metastases

According to Prof. Kunstfeld, an interesting case occurred in a 74-year-old woman who fell at home and broke her left femur. During the subsequent immediate surgery, the doctor noticed suspicious tissue in the bone and surrounding area. Samples were taken and examined microscopically. RESULT: The patient suffered the fracture because of metastases from a BCC, and scintigraphy showed multiple lesions in the femur, spine, and left shoulder.

Inhibition of the Hedgehog signaling pathway

Prof. Dr. med. Dirk Schadendorf, Essen, Germany, presented the experience to date with Hedgehog pathway inhibition in BCC. (Tab. 3). A 2009 phase I clinical trial of the safety and pharmacokinetics of GDC-0449 (vismodegib), an orally active small molecule that targets the Hedgehog pathway, points to its anti-tumor activity in locally advanced or metastatic BCC [1]. The drug was well tolerated, with no dose-limiting toxicities. Nineteen of 33 patients had regressed tumors. For the phase II evaluation [2], a single dose of 150 mg/d was chosen. The results confirmed those of the previous study and led to approval by the Food and Drug Administration (FDA). The drug is also on the market in Switzerland.

Another recent phase II study [3] also demonstrated the effect of vismodegib for patients with Gorlin-Goltz syndrome. The formation of new BCC was inhibited. However, more than half of the patients discontinued participation due to side effects.

“Overall, inhibition of the Hedgehog pathway represents a new treatment pathway for patients with advanced BCC. It also reduces the number of new and the size of existing BCC in those with Gorlin-Goltz syndrome,” Prof. Schadendorf concluded.

New ways of targeted therapy

Prof. Reinhard Dummer, MD, of the University Hospital Zurich, reported on targeted treatment in BCC. Among other things, he emphasized the dual role of primary cilia, cell processes that mediate in the Hedgehog signaling pathway but can also suppress it. The human BCC is often ciliated. Thus, primary cilia have a direct influence on tumorigenesis. Mouse models [4] show that ciliary excision strongly inhibited the growth of BCC-like tumors induced by an activated form of Smoothened (Smo), whereas it accelerated the progression of those induced by an activated GLI2 protein.

“The efficacy of anticancer drugs targeting the Hedgehog pathway will be based on whether activation of this pathway is dependent or independent of primary cilia. Some inhibitors may be ineffective if primary cilia are absent in cancer cells [5],” Prof. Dummer summarized.

Source: “What’s new for basal cell carcinoma?”, Workshop at the 8th World Congress of Melanoma, July 17-20, 2013, Hamburg, Germany.

Literature:

  1. Von Hoff DD, et al: Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma. N Engl J Med 2009; 361: 1164-1172 DOI: 10.1056/NEJMoa0905360.
  2. Sekulic A, et al: Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma. N Engl J Med 2012; 366: 2171-2179 DOI: 10.1056/NEJMoa1113713.
  3. Tang JY, et al. Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome. N Engl J Med 2012; 366: 2180-2188 DOI: 10.1056/NEJMoa1113538.
  4. Wong SY, et al: Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009 September; 15(9): 1055-1061.
  5. Hassounah NB, et al: Molecular pathways: the role of primary cilia in cancer progression and therapeutics with a focus on Hedgehog signaling. Clin Cancer Res 2012; 18(9): 2429-35 DOI: 10.1158/1078-0432.CCR-11-0755. epub 2012 Mar 13.

InFo Oncology & Hematology 2013; 1(1): 44-45.

Autoren
  • Andreas Grossmann
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Basal cell carcinoma
  • BCC
  • cancer
  • Gorlin-Goltz syndrome
  • Hedgehog signaling pathway
  • Inhibitors
  • Kyrotherapy
  • Lymph nodes
  • Metastases
  • Smo
  • Smoothened
  • Tumor
  • WCM Congress
Previous Article
  • New anticoagulants

Questions of practical application are to be clarified

  • Cardiology
  • Congress Reports
  • Neurology
  • RX
View Post
Next Article
  • Award

Thierry Carrel: best trainer in Europe

  • Cardiology
  • Congress Reports
  • News
  • Prevention and health care
  • RX
  • Surgery
View Post
You May Also Like
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.